Sarepta’s ELEVIDYS: First Gene Therapy for Duchenne Muscular Dystrophy (DMD) Treatment Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness. This debilitating condition, primarily affecting young boys, has long posed significant challenges in terms of treatment and management. However, the landscape of Duchenne...
The Evolution of Gene Therapy: Promises and Challengesv
What Does the Future Hold for Gene Therapy in the Duchenne Muscular Dystrophy (DMD) Treatment Market? Duchenne muscular dystrophy (DMD) is a severe and progressive genetic disorder characterized by the degeneration of muscle tissue and loss of motor function, primarily affecting young boys. With no cure currently available, the focus...
What’s More Beyond Exon-Skipping in the Duchenne Muscular Dystrophy Market?
Duchenne Muscular Dystrophy Market: What’s More Beyond Exon-Skipping Therapies? Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. The Duchenne Muscular Dystrophy market has seen significant advancements in recent years, driven by innovative therapeutic approaches beyond traditional exon-skipping therapies. As...
Sternal Wound Infection: Market Insights, Epidemiology, and Forecast for 2032
Sternal Wound Infection: Market Insight, Epidemiology, and Market Forecast - 2032 Introduction Sternal wound infections (SWIs) are a serious complication following sternotomy, a common procedure in cardiac surgeries. These infections can significantly impact patient outcomes, extending hospital stays and increasing healthcare costs. Understanding the market dynamics, epidemiology, and future trends...